| Literature DB >> 34397682 |
Yan Liang1, Shuai Xu, Guanjie Yu, Zhenqi Zhu, Haiying Liu.
Abstract
ABSTRACT: It was reported imperative on cervical sagittal alignment reconstruction after anterior multilevel procedures with self-locked stand-alone cage (SSC) or anterior cage-with-plate (ACP) system multilevel while there was little knowledge about the relationship on cervical alignment and clinical outcomes.To identify the importance of cervical sagittal alignment after 3-level anterior cervical discectomy and fusion on cervical spondylotic myelopathy with SSC and ACP system.Seventy-seven patients with SSC system (SSC group) and 52 cases with ACP system (ACP group) from February 2007 to September 2013 were enrolled with well-matched demographics. Cervical alignment included C2-7 lordosis (CL), operated-segment cervical lordosis (OPCL), upper and lower adjacent-segment cervical lordosis, range of motion of upper and lower adjacent segment at preoperation, immediate postoperation, and the final follow-up. Clinical outcomes contained the neck disability index (NDI), the Japanese Orthopaedic Association (JOA) score, visual analogous scale (VAS) of arm and neck and adjacent segment degeneration (ASD). Patients were then divided into CL improved subgroup (IM subgroup) and non-improved subgroup (NIM subgroup).There were improvements on CL and OPCL in both groups. The change of CL and OPCL larger in ACP group (P < .05) but upper adjacent-segment cervical lordosis/lower adjacent-segment cervical lordosis and range of motion of upper adjacent segment/range of motion of lower adjacent segment were of no significance. NDI, JOA, and VAS got improvement in both groups at immediate postoperation and the final follow-up while ASD was in no difference between SSC and ACP group. A total of 80 patients (39 vs 41) acquired CL improvement with a larger population in ACP group. There were no differences on the rate of ASD, NDI, JOA, VAS, and their change between IM and NIM subgroup. The changes of CL were not correlated to NDI, JOA, VAS, and their change.SSC and ACP group both provide improved OPCL and efficacy on 3-level cervical spondylotic myelopathy with little impact on adjacent segment. The change of CL is not correlated to clinical outcomes.Entities:
Mesh:
Year: 2021 PMID: 34397682 PMCID: PMC8322561 DOI: 10.1097/MD.0000000000026126
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Information of demographics and ACDF on SSC group and ACP group.
| Statistics | SSC group | ACP group | |
| Sex (M: F) | 41:36 | 27:25 | .883 |
| Age, yr | 62.9 ± 8.8 | 63.5 ± 7.7 | .846 |
| BMI, kg/m2 | 24.1 ± 3.5 | 25.7 ± 3.1 | .196 |
| DM (n) | 6 | 3 | .658 |
| Smoking (n) | 13 | 8 | .821 |
| Follow-up (m) | 67.5 ± 5.2 (62–75) | 69.2 ± 6.6 (60–77) | .441 |
| Operated level | .267 | ||
| C3–C6 (n) | 17 | 16 | |
| C4–C7 (n) | 60 | 36 | |
| Operation duration, min | 91.3 ± 16.6 | 115.4 ± 16.1 | <.001 |
| Blood loss, mL | 67.4 ± 39.6 | 62.3 ± 32.7 | .867 |
Figure 1Different types of implants in SSC and ACP system. (A): zero-profile anchored spacer MC+; (B): zero-profile anchored spacer ROI-C; (C): solis cage; (D): anterior cervical plate. ACP = anterior cage-with-plate system, SSC = self-locked stand-alone cage.
Figure 2Measurements of cervical alignment on neutral lateral X-ray. (A): The measurements of CL and OPCL; (B): the measurements of UCL and LCL; (C, D): The measurements of UROM and LROM. CL = C2–7 lordosis, LCL = lower adjacent-segment cervical lordosis, LROM = lower adjacent-segment range of motion, OPCL = operated-segment cervical lordosis, UCL = upper adjacent-segment cervical lordosis, UROM = upper adjacent-segment range of motion.
Intra-observer reproducibility and inter-observer reliability using ICC for all parameters.
| POP | IPO | FFU | ||||
| Parameters | Intra-observer | Inter-observer | Intra-observer | Inter-observer | Intra-observer | Inter-observer |
| CL | 0.87 | 0.79 | 0.83 | 0.76 | 0.93 | 0.88 |
| OPCL | 0.92 | 0.77 | 0.89 | 0.81 | 0.91 | 0.89 |
| UCL | 0.92 | 0.71 | 0.72 | 0.70 | 0.88 | 0.71 |
| LCL | 0.88 | 0.81 | 0.78 | 0.78 | 0.89 | 0.79 |
| UROM | 0.79 | 0.73 | 0.81 | 0.71 | 0.76 | 0.75 |
| LROM | 0.86 | 0.76 | 0.79 | 0.76 | 0.81 | 0.75 |
Comparisons on CL, OPCL, UCL, and LCL between SSC and ACP groups.
| Parameters | SSC group | ACP group | |
| CL at POP, ° | 9.1 ± 12.5 | 3.3 ± 11.7 | .166 |
| CL at IPO, ° | 12.8 ± 10.5 | 8.6 ± 9.8 | .259 |
| CL at FFU, ° | 13.1 ± 8.2 | 11.9 ± 10.5‡ | .728 |
| ΔCL, °§ | 4.0 ± 5.8 | 8.6 ± 7.9 | .026 |
| OPCL at POP, ° | 3.6 ± 9.1 | 2.9 ± 10.9 | .747 |
| OPCL at IPO, ° | 9.6 ± 9.0∗ | 11.9 ± 6.0† | .414 |
| OPCL at FFU, ° | 7.9 ± 7.7 | 11.3 ± 5.9‡ | .263 |
| ΔOPCL, °§ | 4.1 ± 6.0 | 10.2 ± 8.8 | .014 |
| UCL at POP, ° | 4.6 ± 7.2 | 3.4 ± 6.7 | .645 |
| UCL at IPO, ° | 2.8 ± 4.8 | -0.8 ± 3.5 | .037 |
| UCL at FFU, ° | 4.8 ± 6.2 | 1.1 ± 5.1 | .120 |
| ΔUCL, °§ | -0.5 ± 5.8 | -2.0 ± 5.7 | .471 |
| LCL at POP, ° | 4.6 ± 5.9 | 1.5 ± 6.1 | .178 |
| LCL at IPO, ° | 5.2 ± 6.1 | 0.5 ± 10.7 | .145 |
| LCL at FFU, ° | 7.2 ± 6.7 | 0.7 ± 9.4 | .044 |
| ΔLCL, °§ | 2.4 ± 5.5 | -1.1 ± 5.3 | .083 |
| UROM at POP, ° | 9.3 ± 3.5 | 10.5 ± 6.2 | .586 |
| UROM at FFU, ° | 12.8 ± 3.8† | 13.6 ± 4.7† | .616 |
| ΔUROM, °§ | 3.7 ± 4.6 | 3.3 ± 7.7 | .864 |
| LROM at POP, ° | 5.8 ± 4.5 | 6.4 ± 3.6 | .721 |
| LROM at FFU, ° | 10.1 ± 3.2‡ | 9.9 ± 5.6† | .344 |
| ΔLROM, °§ | 4.8 ± 6.7 | 3.1 ± 5.5 | .297 |
Comparisons on clinical outcomes between SSC and ACP groups.
| Parameters | SSC group | ACP group | |
| NDI at POP | 37.6 ± 2.8 | 38.5 ± 3.2 | .406 |
| NDI at IPO | 19.9 ± 8.6∗ | 18.4 ± 4.1∗ | .579 |
| NDI at FFU | 12.5 ± 9.9†,‡,§ | 12.5 ± 5.9†,‡,§ | .992 |
| Δ1NDI|| | 17.9 ± 8.5 | 20.4 ± 4.1 | .364 |
| Δ2NDI|| | 25.3 ± 10.4 | 26.3 ± 4.5 | .759 |
| JOA at POP | 10.5 ± 1.7 | 10.1 ± 2.1 | .561 |
| JOA at IPO | 14.5 ± 1.7∗ | 14.8 ± 0.9∗ | .616 |
| JOA at FFU | 15.9 ± 2.2† | 15.5 ± 1.6†,‡ | .565 |
| RR1 of JOA (%)|| | 60.3 ± 30.0 | 68.2 ± 11.1 | .399 |
| RR2 of JOA (%)|| | 82.7 ± 36.3 | 80.6 ± 19.0 | .865 |
| VAS of arm at POP | 8.1 ± 0.9 | 7.8 ± 1.2 | .447 |
| VAS of arm at IPO | 3.5 ± 1.1∗ | 2.5 ± 0.8∗ | .019 |
| VAS of arm at FFU | 0.7 ± 1.5†,‡,§ | 0.7 ± 1.7†,‡,§ | .999 |
| Δ1VAS of arm|| | 4.8 ± 1.3 | 5.3 ± 1.1 | .333 |
| Δ2VAS of arm|| | 7.6 ± 1.7 | 7.1 ± 1.9 | .470 |
| VAS of neck at POP | 5.4 ± 1.6 | 6.0 ± 1.7 | .340 |
| VAS of neck at IPO | 2.1 ± 1.6∗ | 2.3 ± 1.2∗ | .719 |
| VAS of neck at FFU | 0.7 ± 2.1†,‡,§ | 0.8 ± 1.3†,‡,§ | .808 |
| Δ1VAS of neck|| | 3.4 ± 1.5 | 3.8 ± 1.4 | .459 |
| Δ2VAS of neck|| | 4.9 ± 2.3 | 5.3 ± 1.8 | .564 |
Comparisons on clinical outcomes between IM and NIM subgroups.
| Parameters | IM subgroup | NIM subgroup | |
| NDI at FFU | 11.9 ± 6.8 | 13.7 ± 11.0 | .618 |
| ΔNDI | 26.4 ± 6.7 | 24.6 ± 11.0 | .592 |
| JOA at FFU | 15.9 ± 1.5 | 15.4 ± 2.7 | .575 |
| RR of JOA (%) | 84.1 ± 20.6 | 77.2 ± 43.2 | .578 |
| VAS of arm at FFU | 0.56 ± 1.54 | 0.89 ± 1.69 | .612 |
| ΔVAS of arm | 7.33 ± 1.81 | 7.44 ± 1.88 | .883 |
| VAS of neck at FFU | 1.00 ± 2.06 | 0.22 ± 0.44 | .277 |
| ΔVAS of neck | 5.22 ± 2.34 | 4.78 ± 1.30 | .603 |
| ASD (n) | 48 | 33 | .281 |
Figure 3Typical cases referred to CL and clinical outcomes. (A, B): The X-ray at POP and FFU of a 76-year-old man with the largest positive CL. The case from SSC group performed C3–6 with MC+ showed CL was 29.7° with NDI of 9, ΔNDI of 27, JOA of 16, JOA-RR of 85.7%, arm-VAS of 0, and neck-VAS of 0 at FFU. (C, D): The X-ray at POP and FFU of a 64-year-old woman with the largest negative CL. The case from ACP group performed C3–6 with Solis cage+plate showed CL was –8.2° with NDI of 6, ΔNDI of 27, JOA of 17, JOA-RR of 100%, arm-VAS of 0 and neck-VAS of 0 at FFU; (E, F): the X-ray at POP and FFU of a 67-year-old woman with the largest improvement of CL. The case from ACP group and IM subgroup performed C4–7 with MC+ cage+plate showed ΔCL was 26° with NDI of 15, ΔNDI of 26, JOA of 15, JOA-RR of 75%, arm-VAS of 1 and neck-VAS of 2 at FFU; (G, H): the X-ray at POP and FFU of a 52-year-old man with the largest decrease of CL. The case from SSC group and NIM subgroup performed C4–7 with ROI-C showed ΔCL was –11.3° with NDI of 11, ΔNDI of 31, JOA of 17, JOA-RR of 100%, arm-VAS of 1, and neck-VAS of 0 at FFU. ACP = anterior cage-with-plate system, CL = C2–7 lordosis, FFU = the final follow-up, IM = improvement, JOA = the Japanese Orthopaedic Association, NDI = the neck disability index, NIM = no improvement, POP = preoperation, RR = recovery rate, SSC = self-locked stand-alone cage. Δ means the change of parameters at FFU compared to POP.
Pearson correlation analysis between clinical outcomes and the change of CL.
| Δ∗CL and NDI at FFU | –0.164 | .412 |
| ΔCL and ΔNDI | 0.162 | .420 |
| ΔCL and JOA at FFU | 0.213 | .285 |
| ΔC and RR of JOA | 0.215 | .282 |
| Δ∗CL and VAS of arm at FFU | -0.296 | .134 |
| ΔCL and ΔVAS of arm | 0.183 | .361 |
| Δ∗CL and VAS of neck at FFU | 0.255 | .200 |
| ΔCL and ΔVAS of neck | 0.115 | .567 |